Zobrazeno 1 - 8
of 8
pro vyhledávání: '"O Yu Agapova"'
Publikováno v:
Системные гипертензии, Vol 12, Iss 1, Pp 65-69 (2015)
Objective. To examine the safety of beta-agonists (BA) with different duration of action in patients with arterial hypertension (AH) and chronic obstructive pulmonary disease (COPD) or bronchial asthma (BA).Materials and methods: 40 patients (22 - ma
Externí odkaz:
https://doaj.org/article/ccc3cbf8579d4509ae2ab37c928b9ece
Publikováno v:
Системные гипертензии, Vol 10, Iss 2, Pp 69-74 (2013)
In recent decades cardiovascular (CVD) and COPD diseases are widespread around the world, leading to a high prevalence of patients with comorbidity, especially arterial hypertension (AH) and chronic obstructive pulmonary disease (COPD) and/or bronchi
Externí odkaz:
https://doaj.org/article/7e93b20586f449e78b5dc725eb6ebdf3
Publikováno v:
Системные гипертензии, Vol 9, Iss 3, Pp 54-59 (2012)
Externí odkaz:
https://doaj.org/article/2c5e7f1a463b45f4af72d1425b060e19
Publikováno v:
Системные гипертензии, Vol 9, Iss 1, Pp 54-58 (2012)
Externí odkaz:
https://doaj.org/article/761a29752a93497da355f2b3ea163e11
Autor:
S. Yu. Nistor, A V Rvacheva, L. Ambatiello, E. V. Smolyakova, T V Kuznetsova, N. Skoblova, I E Chazova, O Yu Agapova, Yu. S. Skoblov, V. P. Masenko, A. A. Klimova, Kirill Zykov
Publikováno v:
Russian Journal of Bioorganic Chemistry. 45:129-134
A radioligand-based method was proposed for quantifying the binding activity of β1-adrenergic receptors (ARs) on the surface of human T lymphocytes. Using the transfected HEK293 cell lines expressing β1-AR (ADL-7A) and β2-AR (A2R9) as a model, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8f04988e06f11e9d92188ecd8070ab5
https://doi.org/10.1134/s1068162019020134
https://doi.org/10.1134/s1068162019020134
Autor:
K A Senkevich, K. V. Simakov, N. V. Skripchenko, A D Chaykovskaya, M A Novozhilova, O Yu Agapova, M P Topuzova, T M Alekseeva, Ivan Ternovykh
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 120(5)
Opsoclonus-myoclonus syndrome (OMS) is a very rare condition with various etiologies (paraneoplastic, parainfectious, toxic, idiopathic, etc.) with an autoimmune pathogenetic mechanism of development. The authors describe the case of OMS in a 41-year
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25b9a7d400a9d9c5373c47c9b0377e3c
https://pubmed.ncbi.nlm.nih.gov/32621474
https://pubmed.ncbi.nlm.nih.gov/32621474
Publikováno v:
Системные гипертензии, Vol 12, Iss 1, Pp 65-69 (2015)
Objective. To examine the safety of beta-agonists (BA) with different duration of action in patients with arterial hypertension (AH) and chronic obstructive pulmonary disease (COPD) or bronchial asthma (BA).Materials and methods: 40 patients (22 - ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a309bf4fe8e12134ceb04c6f3be4aa3c
https://doi.org/10.26442/sg29098
https://doi.org/10.26442/sg29098
Autor:
Lyudmila Gennadievna Ratova, Kirill Zykov, I E Chazova, O Yu Agapova, Yu A Dolgusheva, B M Nazarov
Publikováno v:
Системные гипертензии, Vol 10, Iss 2, Pp 69-74 (2013)
In recent decades cardiovascular (CVD) and COPD diseases are widespread around the world, leading to a high prevalence of patients with comorbidity, especially arterial hypertension (AH) and chronic obstructive pulmonary disease (COPD) and/or bronchi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaee275f55c24d10accc85052a285305
https://syst-hypertension.ru/2075-082X/article/view/28973
https://syst-hypertension.ru/2075-082X/article/view/28973